Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.
Epigenetic Modifications and Therapy in Multiple Sclerosis.
Protective Effect of Low-Intensity Pulsed Ultrasound on Memory Impairment and Brain Damage in a Rat Model of Vascular Dementia.
Lymphoid chemokines in the CNS.
Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust.
Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
Role of C16, angiopoietin-1 and regeneration gene protein 2 in attenuating inflammation in an experimental rat model of autoimmune encephalomyelitis.
JCV serology in time: 3 years of follow-up.
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
Managing the Quality of Life in Patients with Multiple Sclerosis: A Literature Review.
Vibration Training Improves Disability Status Among Individuals With Multiple Sclerosis: 1477 Board #130 June 2, 9: 00 AM - 10: 30 AM.
Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis.
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Acute Disseminated Encephalomyelitis.
Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey.
Optic neuropathy associated with systemic sarcoidosis.
Pages
« first
‹ previous
…
782
783
784
785
786
787
788
789
790
…
next ›
last »